Screening cuts cervical cancer rates by half

In the wake of Jade Goody's tragic story, the latest Cancer Research UK statistics reveal that there is hope on the horizon for cervical cancer.

The figures show that women are now half as likely to be diagnosed with cervical cancer as they were when the NHS Cervical Screening Programme began in 1988.

The rate of women diagnosed with the disease has halved from 16 per 100,000 in 1988 to 8 per 100,000 according to the latest figures.

In the late 1980s around 4,800 women were diagnosed with cervical cancer each year in Great Britain. Now, after 20 years of screening only around 2,700 women are diagnosed with the disease.

Before the programme started cervical cancer was the sixth most commonly diagnosed cancer in women. But because of screening, twenty years later, it is now ranked 13th.

Sara Hiom, Cancer Research UK's director of health information, said: "These compelling figures show how effective the programme has been in preventing the disease and saving lives. Screening works by picking up early changes in the cervix before they can develop into cancer."

The number of deaths from cervical cancer has also seen a huge drop. Twenty years ago more than 2,000 women died in Britain every year from the disease compared to 921 in 2006. This means cervical cancer is no longer one of the top 20 most common causes of cancer death.

But, the latest reports show that the number of women taking up their invitations for screening is falling, particularly among those aged 25-34.

Sara Hiom said: "Even though cervical cancer is no longer in the top 10 of all cancers, it is still the second most common cancer for women under the age of 35. Crucially, women must attend screening as soon as they receive the invitation letter from their GP - it could save their lives. If signs of the disease are picked up early then treatment is easy and effective."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Adding high-dose IV vitamin C to chemotherapy can boost survival for pancreatic cancer patients